Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association

American Heart Association Council on Cardiovascular Disease in the Young; Council on Genomic and Precision Medicine; and Council on Peripheral Vascular Disease

Research output: Contribution to journalArticle

Abstract

Girls and women with Turner syndrome face a lifelong struggle with both congenital heart disease and acquired cardiovascular conditions. Bicuspid aortic valve is common, and many have left-sided heart obstructive disease of varying severity, from hypoplastic left-sided heart syndrome to minimal aortic stenosis or coarctation of the aorta. Significant enlargement of the thoracic aorta may progress to catastrophic aortic dissection and rupture. It is becoming increasingly apparent that a variety of other cardiovascular conditions, including early-onset hypertension, ischemic heart disease, and stroke, are the major factors reducing the life span of those with Turner syndrome. The presentations and management of cardiovascular conditions in Turner syndrome differ significantly from the general population. Therefore, an international working group reviewed the available evidence regarding the diagnosis and treatment of cardiovascular diseases in Turner syndrome. It is recognized that the suggestions for clinical practice stated here are only the beginning of a process that must also involve the establishment of quality indicators, structures and processes for implementation, and outcome studies.

Original languageEnglish (US)
Pages (from-to)e000048
JournalCirculation. Genomic and precision medicine
Volume11
Issue number10
DOIs
StatePublished - Oct 1 2018

Fingerprint

Turner Syndrome
Aortic Coarctation
Health
Heart Diseases
Hypoplastic Left Heart Syndrome
Aortic Rupture
Aortic Valve Stenosis
Thoracic Aorta
Myocardial Ischemia
Dissection
Cardiovascular Diseases
Stroke
Outcome Assessment (Health Care)
Hypertension
Population
Therapeutics

Keywords

  • AHA Scientific Statements
  • aortic aneurysm
  • genetics
  • heart diseases
  • pregnancy
  • Turner syndrome

Cite this

American Heart Association Council on Cardiovascular Disease in the Young; Council on Genomic and Precision Medicine; and Council on Peripheral Vascular Disease (2018). Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association. Circulation. Genomic and precision medicine, 11(10), e000048. https://doi.org/10.1161/HCG.0000000000000048

Cardiovascular Health in Turner Syndrome : A Scientific Statement From the American Heart Association. / American Heart Association Council on Cardiovascular Disease in the Young; Council on Genomic and Precision Medicine; and Council on Peripheral Vascular Disease.

In: Circulation. Genomic and precision medicine, Vol. 11, No. 10, 01.10.2018, p. e000048.

Research output: Contribution to journalArticle

American Heart Association Council on Cardiovascular Disease in the Young; Council on Genomic and Precision Medicine; and Council on Peripheral Vascular Disease 2018, 'Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association', Circulation. Genomic and precision medicine, vol. 11, no. 10, pp. e000048. https://doi.org/10.1161/HCG.0000000000000048
American Heart Association Council on Cardiovascular Disease in the Young; Council on Genomic and Precision Medicine; and Council on Peripheral Vascular Disease. Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association. Circulation. Genomic and precision medicine. 2018 Oct 1;11(10):e000048. https://doi.org/10.1161/HCG.0000000000000048
American Heart Association Council on Cardiovascular Disease in the Young; Council on Genomic and Precision Medicine; and Council on Peripheral Vascular Disease. / Cardiovascular Health in Turner Syndrome : A Scientific Statement From the American Heart Association. In: Circulation. Genomic and precision medicine. 2018 ; Vol. 11, No. 10. pp. e000048.
@article{b7e9e6b81537477faa246250f8ad5a4e,
title = "Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association",
abstract = "Girls and women with Turner syndrome face a lifelong struggle with both congenital heart disease and acquired cardiovascular conditions. Bicuspid aortic valve is common, and many have left-sided heart obstructive disease of varying severity, from hypoplastic left-sided heart syndrome to minimal aortic stenosis or coarctation of the aorta. Significant enlargement of the thoracic aorta may progress to catastrophic aortic dissection and rupture. It is becoming increasingly apparent that a variety of other cardiovascular conditions, including early-onset hypertension, ischemic heart disease, and stroke, are the major factors reducing the life span of those with Turner syndrome. The presentations and management of cardiovascular conditions in Turner syndrome differ significantly from the general population. Therefore, an international working group reviewed the available evidence regarding the diagnosis and treatment of cardiovascular diseases in Turner syndrome. It is recognized that the suggestions for clinical practice stated here are only the beginning of a process that must also involve the establishment of quality indicators, structures and processes for implementation, and outcome studies.",
keywords = "AHA Scientific Statements, aortic aneurysm, genetics, heart diseases, pregnancy, Turner syndrome",
author = "{American Heart Association Council on Cardiovascular Disease in the Young; Council on Genomic and Precision Medicine; and Council on Peripheral Vascular Disease} and Michael Silberbach and Roos-Hesselink, {Jolien W.} and Andersen, {Niels H.} and Braverman, {Alan C.} and Nicole Brown and Collins, {R. Thomas} and {De Backer}, Julie and Eagle, {Kim A.} and Hiratzka, {Loren F.} and Johnson, {Walter H.} and Daniella Kadian-Dodov and Leo Lopez and Mortensen, {Kristian H.} and Prakash, {Siddharth K.} and Elizabeth Ratchford and Arwa Saidi and {van Hagen}, Iris and Young, {Luciana T.}",
year = "2018",
month = "10",
day = "1",
doi = "10.1161/HCG.0000000000000048",
language = "English (US)",
volume = "11",
pages = "e000048",
journal = "Circulation. Genomic and precision medicine",
issn = "1942-325X",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "10",

}

TY - JOUR

T1 - Cardiovascular Health in Turner Syndrome

T2 - A Scientific Statement From the American Heart Association

AU - American Heart Association Council on Cardiovascular Disease in the Young; Council on Genomic and Precision Medicine; and Council on Peripheral Vascular Disease

AU - Silberbach, Michael

AU - Roos-Hesselink, Jolien W.

AU - Andersen, Niels H.

AU - Braverman, Alan C.

AU - Brown, Nicole

AU - Collins, R. Thomas

AU - De Backer, Julie

AU - Eagle, Kim A.

AU - Hiratzka, Loren F.

AU - Johnson, Walter H.

AU - Kadian-Dodov, Daniella

AU - Lopez, Leo

AU - Mortensen, Kristian H.

AU - Prakash, Siddharth K.

AU - Ratchford, Elizabeth

AU - Saidi, Arwa

AU - van Hagen, Iris

AU - Young, Luciana T.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Girls and women with Turner syndrome face a lifelong struggle with both congenital heart disease and acquired cardiovascular conditions. Bicuspid aortic valve is common, and many have left-sided heart obstructive disease of varying severity, from hypoplastic left-sided heart syndrome to minimal aortic stenosis or coarctation of the aorta. Significant enlargement of the thoracic aorta may progress to catastrophic aortic dissection and rupture. It is becoming increasingly apparent that a variety of other cardiovascular conditions, including early-onset hypertension, ischemic heart disease, and stroke, are the major factors reducing the life span of those with Turner syndrome. The presentations and management of cardiovascular conditions in Turner syndrome differ significantly from the general population. Therefore, an international working group reviewed the available evidence regarding the diagnosis and treatment of cardiovascular diseases in Turner syndrome. It is recognized that the suggestions for clinical practice stated here are only the beginning of a process that must also involve the establishment of quality indicators, structures and processes for implementation, and outcome studies.

AB - Girls and women with Turner syndrome face a lifelong struggle with both congenital heart disease and acquired cardiovascular conditions. Bicuspid aortic valve is common, and many have left-sided heart obstructive disease of varying severity, from hypoplastic left-sided heart syndrome to minimal aortic stenosis or coarctation of the aorta. Significant enlargement of the thoracic aorta may progress to catastrophic aortic dissection and rupture. It is becoming increasingly apparent that a variety of other cardiovascular conditions, including early-onset hypertension, ischemic heart disease, and stroke, are the major factors reducing the life span of those with Turner syndrome. The presentations and management of cardiovascular conditions in Turner syndrome differ significantly from the general population. Therefore, an international working group reviewed the available evidence regarding the diagnosis and treatment of cardiovascular diseases in Turner syndrome. It is recognized that the suggestions for clinical practice stated here are only the beginning of a process that must also involve the establishment of quality indicators, structures and processes for implementation, and outcome studies.

KW - AHA Scientific Statements

KW - aortic aneurysm

KW - genetics

KW - heart diseases

KW - pregnancy

KW - Turner syndrome

UR - http://www.scopus.com/inward/record.url?scp=85055604047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055604047&partnerID=8YFLogxK

U2 - 10.1161/HCG.0000000000000048

DO - 10.1161/HCG.0000000000000048

M3 - Article

C2 - 30354301

AN - SCOPUS:85055604047

VL - 11

SP - e000048

JO - Circulation. Genomic and precision medicine

JF - Circulation. Genomic and precision medicine

SN - 1942-325X

IS - 10

ER -